Peter J. Weiler - 27 May 2026 Form 4 Insider Report for Edesa Biotech, Inc. (EDSA)

Reporting relationship: Chief Financial Officer
Issuer ticker: EDSA
Reported as of: 27 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 29 May 2026, 17:01:31 UTC
Prior SEC filing: 02 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ Peter J. Weiler

Key filing fact

Peter J. Weiler filed Form 4 for Edesa Biotech, Inc. (EDSA) on 29 May 2026.

Key facts

This page summarizes Peter J. Weiler's Form 4 filing for Edesa Biotech, Inc. (EDSA).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 29 May 2026, 17:01.

Change

Previous filing in this sequence was filed on 02 Jun 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002066576 Primary reporting owner

Weiler Peter J.

Relationship: Chief Financial Officer
Address: C/O EDESA BIOTECH INC., 100 SPY COURT, MARKHAM, ONTARIO, CANADA
Signature: /s/ Peter J. Weiler
Signature date: 29 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EDSA transaction

Common Shares

Award

Transaction value
Shares: +64,609
Change %: +99%
Price: $0.000000^*
Shares after: 129,609
Date: 27 May 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest monthly in equal proportions over thirty-six (36) months, commencing on the grant date.